Business · 01/05/2014Updated: 10/17/2026 · 1 min read
FDA Announces Approval of Expedited Programs for Serious Conditions-Drugs and Biologics Guidance
Summary
The Food and Drug Administration (FDA) has received approval from the Office of Management and Budget (OMB) to collect information on expedited programs for serious conditions, specifically drugs and biologics, under the Paperwork Reduction Act of 1995.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →